Long COVID
Infectious Diseases
2
Pipeline Programs
4
Companies
4
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
ExThera MedicalCA - Martinez
1 programSeraph® 100 Microbind® Affinity Blood FilterN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
ImmunityBioN-803
ImmunityBioAnktiva
ExThera MedicalSeraph® 100 Microbind® Affinity Blood Filter
Maxwell BiosciencesRNA Biomarker Blood Test
Clinical Trials (4)
Total enrollment: 384 patients across 4 trials
A Study to Assess Anktiva in Patients With Long Covid-19.
Start: Oct 2025Est. completion: Oct 202620 patients
Phase 2Not Yet Recruiting
A Study to Examine Anktiva for the Treatment of COVID-19.
Start: Sep 2025Est. completion: Jul 202640 patients
Phase 2Recruiting
Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC)
Start: Feb 2025Est. completion: Apr 2025100 patients
N/ANot Yet Recruiting
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
Start: Mar 2024Est. completion: Mar 2026224 patients
N/ARecruiting
Related Jobs in Infectious Diseases
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
6h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
6h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
10h ago
$179K - $237K/yr
First Line Sales Leader (Medan)
GSK
Indonesia - Sumatera Utara
23h ago
General Worker
GSK
Pakistan - Sindh - Karachi
23h ago
Vaccine Business Manager (Jakarta)
GSK
Indonesia - DKI Jakarta
23h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 384 patients
4 companies competing in this space